Additionally, our data based on a pilot experiment in light and dark suggested that the difference in the progression of arteriosclerosis between these mouse strains (Ldlr −/− vs. Ldlr −/− Per2 m/m) was not detectable within 20 weeks after HFD treatment (Fig. S2). This evidence concerns the gene LDLR and arteriosclerosis disorder.